Biological E, Recbio ink pact to make HP9 vax in India

Biological E Ltd. has partnered with Jiangsu Recbio Technology to commercialize the latter's HPV9 vaccine, REC603, in India. Recbio will supply the drug substance and technology for formulation and packaging. Biological E gains exclusive rights for the Indian market and can participate in UNICEF and PAHO tenders, expanding access to this crucial cancer-preventing vaccine.

Most Recent